Ulf Bergman

9.3k total citations · 1 hit paper
178 papers, 6.6k citations indexed

About

Ulf Bergman is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Ulf Bergman has authored 178 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Economics and Econometrics, 33 papers in Pediatrics, Perinatology and Child Health and 33 papers in Geriatrics and Gerontology. Recurrent topics in Ulf Bergman's work include Pharmaceutical Practices and Patient Outcomes (33 papers), Pharmaceutical studies and practices (22 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Ulf Bergman is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (33 papers), Pharmaceutical studies and practices (22 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Ulf Bergman collaborates with scholars based in Sweden, Denmark and United States. Ulf Bergman's co-authors include Björn Wettermark, Anders Sundström, B Westerholm, Göran Isacsson, Niklas Hammar, Måns Rosén, Petra Otterblad Olausson, Ingemar Persson, B.‐E. Wiholm and Michael M. Hutchison and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes Care.

In The Last Decade

Ulf Bergman

174 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

2006 1.5k citations Björn Wettermark, Ulf Bergman et al. Pharmacoepidemiology and Drug Safety profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulf Bergman Sweden	43	1.2k	1.0k	944	913	844	178	6.6k
Ron M. C. Herings Netherlands	47	717 0.6×	675 0.6×	803 0.9×	579 0.6×	1.1k 1.2×	247	8.4k
Eibert R. Heerdink Netherlands	42	763 0.6×	708 0.7×	1.7k 1.8×	1.1k 1.2×	862 1.0×	236	6.5k
Anton Pottegård Denmark	46	944 0.8×	991 1.0×	1.1k 1.2×	1.0k 1.1×	621 0.7×	385	10.0k
Morten Andersen Denmark	44	898 0.7×	752 0.7×	756 0.8×	514 0.6×	351 0.4×	211	6.6k
Almut G. Winterstein United States	33	468 0.4×	920 0.9×	841 0.9×	1.3k 1.4×	562 0.7×	250	5.6k
Alexander M. Walker United States	61	1.3k 1.1×	646 0.6×	1.1k 1.2×	398 0.4×	1.0k 1.2×	206	11.9k
Hubert G. M. Leufkens Netherlands	58	2.4k 2.0×	1.4k 1.4×	990 1.0×	1.1k 1.2×	826 1.0×	415	14.4k
Gianluca Trifirò Italy	46	983 0.8×	986 0.9×	795 0.8×	888 1.0×	821 1.0×	270	7.0k
Björn Wettermark Sweden	41	1.8k 1.4×	966 0.9×	705 0.7×	863 0.9×	355 0.4×	214	7.1k
Sean Hennessy United States	50	732 0.6×	567 0.5×	614 0.7×	746 0.8×	807 1.0×	268	8.7k

Countries citing papers authored by Ulf Bergman

Since Specialization

Citations

This map shows the geographic impact of Ulf Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Bergman more than expected).

Fields of papers citing papers by Ulf Bergman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Bergman. The network helps show where Ulf Bergman may publish in the future.

Co-authorship network of co-authors of Ulf Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Bergman. A scholar is included among the top collaborators of Ulf Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Bergman. Ulf Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mugisha, Michael, et al.. (2023). Efficacy of Single-Dose Albendazole for the Treatment of Soil-Transmitted Helminthic Infections among School Children in Rwanda—A Prospective Cohort Study. Pharmaceuticals. 16(2). 139–139. 6 indexed citations

Mugisha, Michael, et al.. (2022). Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study. Drug Safety. 45(8). 909–922. 7 indexed citations

Helldén, Anders, et al.. (2015). Development of a computerised decisions support system for renal risk drugs targeting primary healthcare. BMJ Open. 5(7). e006775–e006775. 9 indexed citations

Helldén, Anders, Ingegerd Odar‐Cederlöf, Göran Nilsson, et al.. (2013). Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly. BMJ Open. 3(4). e002686–e002686. 32 indexed citations

Wettermark, Björn, et al.. (2013). Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open. 3(5). e002378–e002378. 91 indexed citations

Cars, Thomas, Björn Wettermark, Rickard E. Malmström, et al.. (2012). Extraction of Electronic Health Record Data in a Hospital Setting : Comparison of Automatic and Semi-Automatic Methods Using Anti-TNF Therapy as Model. Pharmacoepidemiology and Drug Safety. 21. 175–176. 2 indexed citations

Bergman, Ulf, Yin‐Wong Cheung, & Kon S. Lai. (2010). The common-trend and transitory dynamics in real exchange rate fluctuations. Applied Economics. 43(1). 1–18. 8 indexed citations

Helldén, Anders, et al.. (2009). Adverse Drug Reactions and Impaired Renal Function in Elderly Patients Admitted to the Emergency Department. Drugs & Aging. 26(7). 595–606. 65 indexed citations

Shen, Xuzhuang, Yi Wang, Yuan Chen, et al.. (2008). Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children’s hospitals. European Journal of Clinical Pharmacology. 64(8). 821–828. 35 indexed citations

10.

Vlahović–Palčevski, Vera, Uga Dumpis, Piret Mitt, et al.. (2006). Benchmarking antimicrobial drug use at university hospitals in five European countries. Clinical Microbiology and Infection. 13(3). 277–283. 37 indexed citations

11.

Isacsson, Göran, Per Holmgren, Henrik Druid, & Ulf Bergman. (1999). Psychotropics and suicide prevention. The British Journal of Psychiatry. 174(3). 259–265. 60 indexed citations

12.

Bergman, Ulf & Gunnar Isacsson. (1998). Use of calcium channel blockers and risk of suicide. BMJ. 317(7165). 1076–1076. 3 indexed citations

13.

Bergman, Ulf & Michael M. Hutchison. (1997). Economic Expansions and Fiscal Contractions: International Evidence and the 1982 Danish Stabilization. SSRN Electronic Journal. 2 indexed citations

14.

Bergman, Ulf & Michael M. Hutchison. (1996). The 'German View,' Fiscal Consolidation and Consumption Booms: Empirical Evidence from Denmark. SSRN Electronic Journal. 5 indexed citations

15.

Wasserman, D., et al.. (1994). Use of antidepressants among people committing suicide in Sweden. BMJ. 308(6927). 506–509. 102 indexed citations

16.

Strom, Brian L., Jeffrey L. Carson, Allan C. Halpern, et al.. (1991). Using a claims database to investigate drug‐induced Stevens‐Johnson syndrome. Statistics in Medicine. 10(4). 565–576. 63 indexed citations

17.

Anderson, Geoffrey M., et al.. (1990). Benefits, risks, and costs of prescription drugs: A scientific basis for evaluating policy options. Clinical Pharmacology & Therapeutics. 48(2). 111–119. 10 indexed citations

18.

Sanz, Emílio J., et al.. (1989). Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. European Journal of Clinical Pharmacology. 37(1). 65–68. 41 indexed citations

19.

Bergman, Ulf. (1989). Pharmaco-epidemiological perspectives. Pharmacy World & Science. 11(5). 151–154. 5 indexed citations

20.

Bergman, Ulf, et al.. (1978). Epidemiology of adverse drug reactions to phenformin and metformin.. BMJ. 2(6135). 464–466. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact